Qubigen is an exciting new venture that combines Federated AI technology, quantum chemistry and AI drug design capabilities. Qubigen’s mission is to create the largest global federated proprietary dataset and computational toolbox for AI driven drug design.
This means that multiple entities such as pharmaceutical and biotech companies can work on new molecule discoveries at the same time, thereby shortening drug development pipelines.
Federated AI enables a global ‘collaborative-first’ approach by significantly increasing the access to health technology to a broader range of collaborators. Bringing together Data Access partners to tackle the world’s toughest diseases, we stand a better chance of developing novel medicines that no single company could develop on their own.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Bio21 Institute, 30 Flemington Rd,parkville,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.qubigen.com
- Keywords
- IT Consulting.
- HQ
- Melbourne, Victoria
Qubigen Questions
Qubigen's website is http://www.qubigen.com
Qubigen's LinkedIn profile is https://au.linkedin.com/company/qubigen
Qubigen has
7 employees.
View email and phone details for 7
employees at Qubigen.
Qubigen's industry is
Biotechnology Research
Qubigen's top competitors are
Qubicgen Software Solutions Pvt Ltd,
Melody Mocktail,
The Innovation Factory,
The Florey,
Life Whisperer,
Plano,
Rhythm Biosciences Limited,
Socontra,
Presagen,
Synthesis Research.
Qubigen's categories are Biotechnology Research
Qubigen's founding year is 2024
